Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

University of North Carolina

ClinicalTrials.gov lists University of North Carolina as lead sponsor of 17 trials. It has 11 approved assets.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

14 0 1992 2027

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 4 registered with a 2026 start date. The hollow diamonds on the dashed line are a forecast of the full-year count, planned starts included: about 4 in 2026 and about 6 in 2027, the average of the 24 months through September, counted as registered and carried forward. The columns, the lighter one included, count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. This method has not been backtested on organizations. In backtests on conditions with as many trial starts a year as this organization (5 to 20), forecasts made part-way through the year were typically off by about 28 percent and ran about 20 percent low against the count later registered; forecasts made before the year began were off by about 39 percent and ran about 37 percent low against the count later registered. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored. The 2026 forecast is below the 4 already registered with a 2026 start date: at the cutoff, 2 trials were already registered to start in October to December, more than the method's monthly average allows for, and the method does not use those planned starts.

Logo UNC System, via Wikimedia Commons, CC BY-SA 4.0. Shown to identify the organization; it may be a registered trademark.

This page covers University of North Carolina: 17 lead-sponsored trials and 0 legal-entity registrations.

Get the University of North Carolina report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (161)

Shown in this order: most trials first.

Disease areas
Disease area Trials
HIV Infections 11
Rare Diseases 10
Hemorrhage 7
Breast Neoplasms 6
Cystic Fibrosis 6

Trials by start year as sponsor or collaborator (33)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 4
2025 9
2024 6
2023 10
2022 8
2021 4
2020 4
2019 10
2018 9
2017 10

Recruitment duration, a model prediction: none of the 17 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (11)

Shown in this order: max phase first.

Approved assets
Drug Trials
Avonex/Zocor 1
RABEPRAZOLE SODIUM 1
Amiloride 1
Clotrimazole 1
HYDROXYUREA 1

Journals published in (196)

Shown in this order: most published in first.

Journals published in
Journal Publications
The New England journal of medicine 12
AIDS and behavior 10
Obstetrics and gynecology 10
American journal of respiratory and critical care medicine 8
JMIR research protocols 8

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
104 1 2021-12-14

Organization relationships (14)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Pfizer Inc Co sponsors trial with 3
Nemours Children's Health Co sponsors trial with 1
Asociación para Evitar la Ceguera en México Co sponsors trial with 1
Jennifer Bell Co sponsors trial with 1
Lucile Packard Children's Hospital Stanford Co sponsors trial with 1

Latest dated events (284)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-12-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-08 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-11-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (169)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ACE Trial collaborator Named in trial inclusion criteria
AFP Trial collaborator Named in trial inclusion criteria
ALB Trial collaborator Named in trial inclusion criteria
ALB Trial collaborator Named in trial inclusion criteria
ALK Trial collaborator Named in trial inclusion criteria

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.